(Q37201827)

18 August 2017

A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood (English)

1 reference

18 August 2017

0 references

4

Rakesh K Jain

1 reference

18 August 2017

3

David T Scadden

1 reference

18 August 2017

Dan G Duda

1

1 reference

PMC publication ID

2686125

18 August 2017

Kenneth S Cohen

series ordinal

2

1 reference

18 August 2017

1 January 2007

1 reference

18 August 2017

1 reference

18 August 2017

2

1 reference

18 August 2017

4

1 reference

18 August 2017

805-810

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2007.111

18 August 2017

0 references

cites work

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2686125

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPROT.2007.111

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

31 March 2020

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPROT.2007.111

Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

31 March 2020

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPROT.2007.111

Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17446880

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17446880

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NPROT.2007.111

1 reference

18 August 2017

1 reference

PMC publication ID

2686125

18 August 2017

PubMed publication ID

17446880

1 reference

PMC publication ID

2686125